https://www.selleckchem.com/pr....oducts/ro5126766-ch5
A growing body of scientific evidence points to the potentially harmful cognitive effects of anticholinergic medications among older adults. Most interventions designed to promote deprescribing of anticholinergics have directly targeted healthcare professionals and have had mixed results. Consumer-facing technologies may provide a unique benefit by empowering patients and can complement existing healthcare professional-centric efforts. We initiated a randomized clinical trial to evaluate the effectiveness of a patient-facing
Like
Comment
Share
